[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.107.222. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 26, 1994

(Mis)Treatment of Acute Herpes Zoster

Author Affiliations

Galveston, Tex

Arch Intern Med. 1994;154(18):2109. doi:10.1001/archinte.1994.00420180119014
Abstract

Recent attention has been focused on new antiviral agents for the treatment of herpes zoster both in the medical literature1 and in the lay press (Wall Street Journal. July 12, 1933;B1, 5). Since acyclovir was approved for treatment of herpes zoster in April 1990, we have kept a log at the University of Texas Medical Branch, Galveston, of patients presenting at our clinics who inform us that they were previously treated for shingles by their local physician. Interestingly, only 33 (17%) of 197 of these patients had received acyclovir at the recommended dosage of 800 mg orally five times per day for 7 to 10 days. Another 56% of the patients reported being treated with acyclovir at lower oral dosages and/or with topical acyclovir. The remaining 27% of patients were treated with oral antibacterial agents and/or a variety of other non-antiviral drugs.

As we actively enroll patients in clinical

First Page Preview View Large
First page PDF preview
First page PDF preview
×